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The presence of extended-spectrum β-lactamase (ESBL) or plasmid-mediated AmpC β-lactamase 
(pAmpC)-producing Escherichia coli (ESBL/pAmpC-EC) in livestock is a public health risk given 
the likelihood of their transmission to humans via the food chain. We conducted whole genome 
sequencing on 100 ESBL/pAmpC-EC isolated from the broiler production to explore their resistance 
and virulence gene repertoire, characterise their plasmids and identify transmission events derived 
from their phylogeny. Sequenced isolates carried resistance genes to four antimicrobial classes in 
addition to cephalosporins. Virulence gene analysis assigned the majority of ESBL/pAmpC-EC to 
defined pathotypes. In the complex genetic background of ESBL/pAmpC-EC, clusters of closely 
related isolates from various production stages were identified and indicated clonal transmission. 
Phylogenetic comparison with publicly available genomes suggested that previously uncommon 
eSBL/pAmpc‑ec lineages could emerge in poultry, while others might contribute to the maintenance 
and dissemination of ESBL/pAmpC genes in broilers. The majority of isolates from diverse E. coli 
lineages shared four dominant plasmids (IncK2, IncI1, IncX3 and IncFIB/FII) with identical ESBL/
pAmpC gene insertion sites. These plasmids have been previously reported in diverse hosts, including 
humans. Our findings underline the importance of specific plasmid groups in the dissemination of 
cephalosporin resistance genes within the broiler industry and across different reservoirs.
Third-generation-cephalosporins (3GCs) are critically important antimicrobial agents in human medicine as they 
are amongst the few available treatment options in infections caused by multi-drug resistant Enterobacteriaceae1. 
Their role in the treatment of food-producing animal diseases (e.g. respiratory infections in ruminants, foot rot 
and mastitis in cattle) is as well considered as  crucial2. To preserve the efficacy of 3GCs, their administration in 
poultry within the European Union is not  authorised3 but there is evidence of off-label use in hatcheries, either in 
ovo or subcutaneously in day-old chicks, to prevent early mortality due to Escherichia coli  infections4. Neverthe-
less, several studies suggested that the broiler production system acts as a reservoir of 3GC-resistant bacteria, such 
as extended-spectrum β-lactamase (ESBL) or plasmid-encoded AmpC β-lactamase (pAmpC)-producing E. coli 
(ESBL/pAmpC-EC), given that their prevalence is higher in the broiler production industry compared to other 
animal  sectors5. Further, presence of ESBL/pAmpC genes on highly transmissible plasmids, which enables their 
dissemination in diverse  reservoirs6, initiated a debate on the exposure risk for consumers via the food  chain7,8. 
However, the connection between human exposure and presence of ESBL/pAmpC-EC in broilers was supported 
by circumstantial evidences showing the presence of identical ESBL/pAmpC genes in closely related E. coli of 
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both hosts inferred by low-resolution typing  methods9,10. The importance of high-resolution, whole genome 
sequencing (WGS) studies in informing and reducing the uncertainty of quantitative microbial risk assessment 
(QMRA) models employed in the risk analysis of foodborne antimicrobial resistance was recently  stressed11,12. 
Such an assessment for the broiler chain would require the thorough characterisation of ESBL/pAmpC-EC and 
their transmission patterns across the production  pyramid5.
In a recent study, we detected a high prevalence of ESBL/pAmpC-EC in an integrated broiler production 
 chain13. Here, we proceeded with the WGS-assisted characterisation of a selection of ESBL/pAmpC-EC isolates 
collected within the formerly published framework. The main aim of the study was to generate high-resolution 
data on ESBL/pAmpC-EC, advance our understanding on their characteristics and epidemiology in the broiler 
production and thus provide valuable information to (parts of) QMRA efforts. Our specific objectives were 
(i) to fully explore the antimicrobial resistance (AMR) and virulence profiles of the isolates (crucial for hazard 
identification) (ii) to characterise ESBL/pAmpC gene-carrying plasmids, study their epidemiology within the 
broiler production chain and assess their relevance in other reservoirs (exposure assessment), (iii) to infer the 
phylogeny of ESBL/pAmpC-EC and identify transmission events within the broiler production (exposure assess-
ment), and (iv) set the isolates of this collection in context with other publicly available genomes and thereby 
assess their presence in other hosts.
Results and discussion
Phylogenetic analysis. In silico typing revealed a complex genetic background in the 100 sequenced E. 
coli isolates by assignment to 31 unique Sequence Types (STs) (Fig. 1). Two novel STs were identified with one 
representing isolate each. The ST9298 isolate was obtained from a breeder and is closely related to ST429 as they 
differ by only one SNP in the icd allele ( T109A, icd13→ icd1072 ). The ST9340 isolate was recovered from a 
day-old broiler chick and is closely related to ST46 of the ST Complex (Cplx) ST10 ( C336T, gyrB1→ gyrB812 ). 
Figure 1.  Phylogenetic analysis of the 100 sequenced isolates. The SNP tree was created with CSI phylogeny. 
Nodes shape and colour indicate the broiler production stage and production chain, respectively. The inner ring 
specifies the ESBL/pAmpC resistance genes identified. The middle ring indicates hierBAPS clusters. The outer 
ring with alternating dark and light grey segments, marks different STs. Scale bar refers to the branch lengths, 
which are measured in the number of substitutions per site.
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Overall, ST457 and ST155 (comprising 25% and 10% of all isolates, respectively) were the most dominant STs 
followed by ST744 (ST10 Cplx; 8%) and ST429 (7%) (Table  1). The majority of the remaining isolates were 
assigned to various STs, represented by less than three isolates each, while ST38 (ST38 Cplx), ST117 and ST2179 
were represented by four isolates each.
Genomes were mapped against the reference genome of E. coli strain MRY15-131 (Accession no. NZ_
AP017620.1). All isolates covered at least 66.3% of the reference genome sequence resulting in a core genome 
alignment of 3.34 Mbp and 148,830 informative single nucleotide polymorphisms (SNPs) (File S2). Cluster 
analysis with hierBAPS revealed the presence of seven clusters. The examined isolates clustered primarily in 
accordance to their ST and subsequently to their ST complex (Fig. 1). Each of the four most dominant STs (ST457, 
ST155, ST744 and ST429/ST9298) was assigned to an independent cluster. For each of these STs, a separate 
in-depth SNP analysis was conducted with suitable reference genomes (File S2) to identify clonal transmission 
events within the studied broiler production pyramid (Fig. S1) and gain insights from the comparative genomic 
analysis with publicly available genomes (Fig. S2).
Among all isolates, ST457 was the most widespread ST (n = 25 isolates), representing isolates from all chains 
and stages of the production pyramid. All ST457 isolates harboured blaCTX-M-55 and exclusively formed Cluster 
1 (Fig. 1). In-depth SNP analysis distinguished two clusters, Cluster 1 and Cluster 2, among the ST457 isolates, 
with a median of pairwise differences (MPD) among all isolates at 3,855 SNPs (Fig. S1a). The cluster 1 (n = 19 
isolates) was formed by closely related isolates (MPD 13 SNPs), retrieved from various stages of all three produc-
tion chains, whereas Cluster 2 (n = 6 isolates) consisted of closely related isolates of chain A, including broiler 
chicks, fattened broilers and carcasses (MPD 19 SNPs) (Fig. S1a). Given that in previous reports epidemiologically 
linked isolates had 0–23  SNPs14, our results indicate a clonal expansion of ST457 in the majority of the production 
chains within the studied broiler production system. ST457 is a rare ST, first reported in the United Kingdom 
as a nosocomial isolate obtained from an urine  sample15. A blaKPC-3-blaCTX-M-55-carrying E. coli isolated from a 
human bloodstream infection in  Italy16 was amongst the few recently reported ST457 isolates. An additional study 
conducted in the United States, showed the concurrent presence of mcr-1 and blaCTX-M-55 on the same plasmid 
carried by an E. coli ST457 obtained from a human urinary tract  infection17. Fifteen out of 22 ST457 genomes at 
Enterobase harboured ESBL/pAmpC genes, but none of them carried blaCTX-M-55 or was isolated from poultry. 
In the SNP analysis, six of our ST457 isolates clustered closely with two human blaCTX-M-1 carrying isolates from 
the Netherlands (unpublished) and one blaCMY-2-carrying isolate from  Germany14 (Cluster 3, Fig. S2a), and these 
nine isolates had a MPD of 142 SNPs. In contrast, the remaining ST457 isolates clustered more distantly (MPD 
638 SNPs) with livestock isolates (Fig. S2a).
In the overall phylogenetic analysis, Cluster 5, the second most diverse cluster in terms of varying ST content 
after Cluster 6 (Fig. 1), was mainly represented by ST155 (n = 10 isolates). Isolates of ST155 formed three clusters 
according to their ESBL/pAmpC gene content (i.e. blaCMY-2, blaCTX-M-1 and blaSHV-12) and the within-cluster SNP 
differences (MPD 5–11 SNPs) suggested clonal dissemination (Fig. S1b). SNP analysis including the respective 
Enterobase genomes showed that ESBL/pAmpC isolates of ST155 are common in  poultry8,14 (n = 22/35 isolates 
were of poultry origin). The isolates of this study were grouped in a large and diverse cluster (MPD 1,355 SNPs) 
mainly of poultry origin, although three human isolates were included in the same cluster (Cluster 1, Fig. S2b).
The second largest and most diverse cluster in terms of included ST groups (Cluster 6; n = 21 isolates, n = 4 
STs), primarily included ST10 Cplx isolates (n = 15) with ST744 as the most prevalent (n = 8 isolates) (Fig. 1). 
ST744-blaSHV-12 E. coli (n = 8/100) isolated from breeders, broilers and carcasses of chain C formed two clusters 
with an MPD of respectively six and 21 SNPs (Fig. S1c). The ESBL/pAmpC isolates of ST744 at Enterobase 
(n = 79) were mainly of human origin, and none of the isolates carried blaSHV-12 or was of poultry origin. Our 
ST744 isolates clustered with a set of human isolates, which mainly carried blaCTX-M-15 (Cluster 4, Fig. S2c). 
We found further evidence for the distribution of ST744 in  animals18 and  humans14,19, which corroborates the 
omnipresence of ST10 Cplx members in both  populations19.
All isolates of Cluster 2, including the novel ST9298 isolate and the closely related ST429 isolates (n = 7), 
harboured blaCMY-2 (Fig. 1). Four out of five isolates from one-day-old, imported Parent Stock (PS) chicks were 
assigned to ST429. The remaining ST429 isolates (n = 3), together with one isolate of the novel ST9298 isolated 
from a PS breeder, were subsequently recovered from broilers and a carcass and belonged to chains A and C 
(Fig. S1d). The MPD of SNPs (43–76 SNPs) among the isolates of each of the three identified clusters (Fig. S1d) 
were generally larger compared to the aforementioned ST groups, even for a set of three isolates that were isolated 
from the same PS breeder flock (Cluster 2, Fig. S1d). Hence, instead of direct clonal transmission, the repeated 
introduction and subsequent circulation of closely related ST429-blaCMY-2 isolates through the import of PS 
chicks in each broiler production cycle may be a more likely scenario. SNP analysis of ST429/ST9298 isolates of 
this study and Enterobase (n = 30) revealed that almost all isolates harboured blaCMY-2, clustered together with 
an MPD of 76 SNPs and were predominantly of poultry origin (Cluster 1, Fig. S2d). The only exception in the 
ST429 dataset was one human blaTEM-52-carrying E. coli, which showed an MPD of 2,976 SNPs to the isolates of 
Cluster 1. The Enterobase isolates originated from various stages of the broiler production, including isolates from 
breeders and poultry meat (not displayed). This finding highlights the existence of a conserved ST429-blaCMY-2 
lineage, which seems to have spread in the European poultry production.
Resistance genes other than ESBL/pAmpC genes. Sulphonamide resistance genes were present in 
89% (n = 89/100) of isolates with the sul2 gene as most prevalent (Table 1). Aminoglycoside acetyltransferase 
genes (aac(3)-like), nucleotidyltransferase genes (aadA-like) and phosphotransferase genes (strA, strB, aph(3′)-
like) were found in 87% of isolates. The tetracycline resistance genes tet(A) and tet(B) were found in 76% and 
12% of the E. coli, respectively. Moreover, WGS data showed trimethoprim resistance conferred by dfrA-like 
genes in 45% of isolates, with dfrA14 being the most prevalent. The chloramphenicol exporter gene floR was pre-
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sent in 21 out of the 43 isolates, which carried phenicol resistance genes, while cmlA1, catA1 and catB3 were also 
present. Plasmid-mediated quinolone resistance (PMQR) genes were identified in 20% of the E. coli, specifically 
qnrS1 (13%), qnrS2 (4%) and qnrB19 (2%). In addition, quinolone resistance was mediated by chromosomal 
mutations in quinolone resistance determining regions (QRDR) in 49% of isolates. The most prevalent muta-
tions were those resulting in the amino acid exchanges Ser83Leu in GyrA (47%), followed by Ser80Ile in ParC 
(34%). Twelve isolates had combinations of PMQR genes and mutations in the gyrA and/or parC genes. In addi-
tion, 14 isolates harboured at least one of the macrolide resistance genes mph(A) or mph(B), which were found 
in twelve and two isolates, respectively. Furthermore, the rifampicin resistance gene arr-3, and the aac(6′)Ib-cr 
gene, which confers resistance to both fluoroquinolones and aminoglycosides, were found in all four ST2179 
isolates of this study (Table 1). Although we did not confirm resistance phenotypes by susceptibility testing, pre-
vious studies showed high accordance between resistance phenotype and  genotype20,21. Multi-drug resistance, 
which is frequently observed in ESBL/pAmpC-EC22,23, is crucial for their selection and dissemination by the use 
of non-β-lactam antimicrobial agents and thus may help to explain the high prevalence of ESBL/pAmpC-EC in 
broilers even in the absence of cephalosporin  use24. Indeed in our case, all PS and fattening broiler flocks, except 
for three, received standard antimicrobial treatments for therapeutic reasons, which mainly included the admin-
istration of amoxicillin for ~ 5 days although occasional use of enrofloxacin and oxytetracycline was recorded as 
 well13. Therefore, antimicrobial administration may have led to the selection of resistant isolates in the chicken 
gut and enabled their further  dissemination24. However, alternative explanations may exist since ESBL/pAmpC 
genes can be maintained in bacterial populations even in the absence of antimicrobial selection pressure through 
conjugation and as a result of their low fitness  cost25. Nevertheless, antimicrobial administration seems to play 
a central role in the complex mechanisms that modulate the abundance of ESBL/pAmpC plasmids in a popula-
tion through the modulation of pathways that lead to their positive or negative frequency-dependent  selection25.
Virulence genes. Overall, 320 different virulence genes (VGs) were identified in the 100 sequenced E. 
coli and individual isolates carried a median of 170 VGs. A total of 56 virulence genes were ubiquitous. These 
included the curli fibers genes (csg), common-pilus genes (ecp), enterobactins (ent), ferrienterobactins (fep), 
the fimbrial proteins fimD and fimG, flagellar proteins of the families flg and fli and the flagellar motor pro-
teins motAB. Only a few of the VGs showed an association with specific STs. While screening for a total of 89 
adherence related VGs, we detected an average of 20 adherence-related VGs per isolate (Fig. 2). The adherence-
conferring pix pili genes (pixCDFXH) were found in 13/100 isolates and are in general connected to uropatho-
genic E. coli (UPEC)26. Moreover, the etp gene cluster (which codes for a type II secretion system) and the 
stcE protease gene, mostly associated with enterohaemorrhagic E. coli O157:H727,28, were found in two and one 
isolates, respectively (File S1). Autotransporters showed a heterogeneous distribution among the various STs. 
From this category, the upaG adhesion gene, associated with UPEC, was found in 41  isolates29. Additionally, the 
temperature-sensitive hemagglutinin autotransporter tsh gene was identified in ST371 isolates (n = 2/100) and 
Figure 2.  Distribution of virulence genes by function in the sequence types identified in this study.
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has previously been linked to avian pathogenic E. coli (APEC)30. With regard to the 33 iron uptake VGs analysed, 
the sit-like iron transporter and iuc-like aerobactin genes were associated with 83.8% (n = 26/31) and 61.3% 
(n = 19/31) of the STs identified in this study, respectively. Furthermore, the toxin haemolysin E (hlyE) gene was 
present in the majority of STs (n = 29/31) and in 83/100 isolates. Most isolates showed the presence of VGs with 
miscellaneous functions (Fig. 2), such as the increased serum survival (iss) gene (n = 87/100), which is a crucial 
VG of extra-intestinal pathogenic E. coli (ExPEC)31, as well as hma (n = 9/100) that encodes a haem acquisition 
protein and plays a critical role in the colonisation of the urinary  tract32. Additionally, the ESBL/pAmpC-EC 
were assigned to pathotypes based on previously defined criteria (File S1)33–36. Interestingly, 56 isolates belong-
ing to 18 different STs were classified as atypical enteroaggregative E. coli (aEAEC) as they possessed aatA but 
lacked the aggR  regulon35,37. About one third (34%) of the aEAEC group was represented by ST457 isolates 
(n = 19/25). In the study of Bamidele et al.36, eight out of 31 adults suffering from travellers’ diarrhoea carried 
aEAEC that harboured only aatA and not aggR or aaiC and were positive in the Hep-2 cell adherence test, which 
remains the gold-standard in the assessment of aEAEC/EAEC  pathogenicity36,37. Both typical and atypical EAEC 
have been predominantly associated with paediatric diarrhoea in developing  countries35,37. Further, 51 isolates 
from 12 STs were characterised as ExPEC [presence of ≥ 2 of pap (P fimbriae), sfa/foc (S/F1C fimbriae), afa/dra 
(Dr binding adhesins), iutA (aerobactin receptor), and kpsMT II (group 2 capsule synthesis)]31,33. All ST457 
isolates (n = 25/25) made up half (49%) of the ExPEC group. Moreover, 39 isolates, belonging to 13 different 
STs, were classified as avian pathogenic E. coli (APEC) [presence of iutA, hlyF (haemolysin F), iss, iroN (sidero-
phore receptor), ompT (outer membrane protein T)]34. The APEC group mainly (38.5%) consisted of ST744 
(n = 8/8) and ST429/ST9298 (n = 7/8) isolates. Interestingly, 42 isolates showed hybrid pathotypes, with 30 iso-
lates from seven STs displaying the aEAEC/ExPEC pathotype (File S1). This latter subgroup was predominantly 
represented by the isolates of ST457 (n = 19/25), suggesting an association of this ST with the aEAEC/ExPEC 
pathotypes, followed by ST155 (n = 4/10). While the possession of ExPEC VGs was expected for the APEC and 
ExPEC pathotypes, it was less anticipated for aEAEC, since it is a potential intestinal pathogenic E. coli (InPEC) 
pathotype. A recent study suggested that such hybrid pathotypes are dominant in human faecal microbiota and 
are usually undetected by routine diagnostic  tests38. Although prediction of pathogenicity is fundamental for 
QMRA models, the distinction between commensals and pathogens has become a bigger conundrum in the 
WGS era. For example, disease-associated VGs were identified in probiotic bacteria with a long history of safe 
 use39. Another study suggested that pathogenicity may be linked to genome reduction rather than the acquisi-
tion of certain  VGs40. It is therefore likely that traditional pathotyping schemes will be modified in the future and 
that multi-omic pathogenicity predictive models that consider the presence and expression of all genes rather 
than small sets will gain more ground as genome databases  grow11. Nevertheless, the virulence gene repertoire of 
ESBL/pAmpC-EC reported here and in other studies, may explain their adaptation to and persistence in various 
niches, such as the poultry  environment41.
Genomic localisation of ESBL/pAmpC genes. ESBL/pAmpC genes were often associated with plas-
mids belonging to specific incompatibility groups and in some cases associations with certain STs were also 
observed. The most dominant ESBL/pAmpC gene/plasmid association was the presence of blaCMY-2 on IncK2 
plasmids, which was found in 27% of the sequenced isolates, belonging to a variety of different STs (11 out of 
31 STs) although predominantly in ST429 (7 out of the 27 blaCMY-2-carrying IncK2 plasmids) (Table 1). Another 
striking association was the occurrence of blaCTX-M-55 on IncFIB/IncFII plasmids (25%), which was uniquely pre-
sent in all isolates of ST457. The blaCTX-M-1 gene was mainly found on IncI1 plasmids (13%), but IncI2, IncFIB/
IncFII and IncHI2 plasmids also harboured this gene (Table 1). Moreover, blaSHV-12 was found to be carried by 
IncX3 or IncI1 plasmids in 12% and 6% of the isolates, respectively (Table 1). For the four blaCTX-M-65-carrying 
ST2179 isolates, the gene was not associated with any plasmid replicons and we thus concluded its putative 
chromosomal localisation, which will be further investigated. The genetic context of the most dominant plasmid 
types is described below.
IncK2 plasmids carrying blaCMY‑2. In 27 of the thirty E. coli genomes harbouring blaCMY-2, the resistance gene 
was associated with the novel incompatibility group  IncK242. An approximately 12 kb large region including 
blaCMY-2 was highly conserved in all plasmids and was almost identical (99.81–100% nucleotide sequence iden-
tity) to that of plasmid pDV45 (GenBank accession no. KR905384.1). ISEcp1-blaCMY-2-blc-sugE was integrated 
into the tra locus between the traU and traT genes in all cases (Fig. 3a). The two imperfect inverted repeats 
(IV-L: TGA CGG TGA TCC T; IV-R: AGC ATC TCC GTC A) described by Seiffert et al.42 flanking this mobile ele-
ment were also identified in those sequences. Recent studies reported the dissemination of the highly conserved 
cluster of IncK2 plasmids in diverse E. coli of various  reservoirs14,43, although they seem to be dominant in 
broilers and broiler  meat44. In our study, IncK2 plasmids were identified in isolates assigned to eleven differ-
ent STs recovered from different stages of the production pyramid (Table 1, Fig. 3a). Interestingly, a further 
comparative analysis with ABACAS of all ST429-blaCMY-2 isolates of poultry origin present in Enterobase using 
plasmid pDV45 as reference, showed in all cases the presence of the aforementioned ISEcp1-blaCMY-2-blc-sugE 
element integrated in IncK2 plasmids (data not shown). It is also noteworthy that plasmids with almost identi-
cal IncK2 backbones have been identified in E. coli isolated from hospitalised  patients42,44. Furthermore, Donà 
et al.45 reported a similar IncK2 plasmid harbouring mcr-1, blaTEM-1 and sul2 but not blaCMY-2 in E. coli from retail 
chicken meat in Switzerland. In our study, blaCMY-2 was the only resistance gene present on IncK2 plasmids with 
the exception of four plasmids that carried also aac(3)-VIa, aadA1 and sul1 (Table 1).
IncI1 plasmids carrying blaCTX‑M‑1. The blaCTX-M-1 gene was mainly detected on IncI1 plasmids (n = 13 of 17), 
which together with IncN plasmids, contribute to the spread of blaCTX-M  genes46. All blaCTX-M-1-carrying IncI1 
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plasmids belonged to plasmid MLST type pST3 or to closely related variants (Table 1). The genetic region con-
taining blaCTX-M-1 (~ 12 kb) was highly conserved amongst all plasmids (99.96% nucleotide sequence identity) 
and the well-studied IncI1 plasmid R64 (GenBank accession no. AP005147) served as a reference (Fig. 3b). The 
mobile element ISEcp1-blaCTX-M-1 was integrated in the shufflon region, between the rci shufflon-specific recom-
binase and the pilV gene, which represent a hotspot for DNA  rearrangements46. Rci binds to specific recombina-
tion sites (sfx repeats) and causes the rearrangement of shufflon segments, which leads to variable arrangements 
of the shufflon region, even within the same plasmid  preparation47, in what seems to be a non-random  process48. 
It is, therefore, highly probable that the observed re-arrangements in the integration site of blaCTX-M-1 (Fig. 3b) do 
not represent multiple insertion events but rather recombination events due to Rci activity. The insertion of the 
module ISEcp1-blaCTX-M-1 into the shufflon region seems to be common for IncI1 plasmids belonging to pST3, 
as shown in previous studies identifying this plasmid type from various  sources46,49–51. A recent study reported 
identical blaCTX-M-1-carrying IncI1 pST3 plasmids from chicken, chicken meat, and bloodstream infections in 
 humans21. Furthermore, additional resistance genes, mainly tet(A) and sul2 (Table 1), were found on the IncI1-
blaCTX-M-1 plasmids and their co-localisation with blaCTX-M-1 has been described  before21,45.
IncX3 plasmids carrying blaSHV‑12. The resistance gene blaSHV-12 was detected in 18 of the sequenced isolates 
and was carried by either IncX3 (n = 12/18) or IncI1 (n = 6/18) plasmids (Table 1). The genetic context of blaSHV-12 
in IncX3 plasmids included two IS26 elements in opposite orientation, with qnrS1 being inserted upstream 
(Fig.  3c). The most similar sequences identified by BLASTn analysis of the ~ 11  kb region against the NCBI 
nucleotide database were ~ 48 kb large IncX3-blaSHV-12-qnrS1 plasmids isolated from chicken faeces and a human 
patient in the Netherlands, reported by Liakopoulos et al. in  201852 (e.g. GenBank accession no. KX618704, 
99.82–100% nucleotide sequence identity). Similar IncX3 plasmids with the same blaSHV-12 surrounding region 
have been isolated from different countries and sources, including  humans52,53. Despite of blaSHV-12 being mainly 
associated with IncI1  plasmids54, in our study we observed a higher occurrence of the IncX3 plasmid com-
pared to IncI1 (Table 1). This shift has also recently been reported in the Netherlands, where a slow decrease of 
blaSHV-12-encoding IncI1 plasmids in favour of IncX3 plasmids was  observed52. Except for blaSHV-12 and qnrS1, no 
additional resistance genes were co-located on IncX3 plasmids.
Figure 3.  Linear comparison of (a) IncK2, (b) IncI1, (c) IncX3 and (d) IncFIB/IncFII plasmid regions carrying 
blaCMY-2, blaCTX-M-1, blaSHV-12 and blaCTX-M-55 genes, respectively, identified in our study. The open reading frames 
are represented with arrows, with the arrowhead indicating the direction of transcription. Their role in transfer, 
recombination, antimicrobial resistance, their association to mobile genetic elements and known or unknown 
functions are colour-coded. Areas shaded in grey indicate the percentage of nucleotide sequence identity.
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[no. of isolates] pMLST/RST
MLST
[no. of isolates]
Additional resistance genes located on ESBL/
pAmpC gene-carrying  plasmidsc Other resistance  genesd
blaCMY-2 IncB/O/K/Z  [27]a – ST429 [7] aac(3)-VIa*, aadA1*, sul1* tet(A)
ST9298 [1] – aac(3)-VIa, aadA1, tet(A), sul1
ST155 [5] – blaTEM-1b*, aac(3)-VIa, aadA1, tet(A), sul1
ST10 [3] – blaTEM-1b*, aac(3)-VIa*, aadA1, dfrA1*, tet(A)*, sul1*
ST140 [2] aac(3)-VIa*, aadA1*, sul1* tet(A)
ST2485 [2] aac(3)-VIa, aadA1, tet(A), sul1
ST371 [2] aac(3)-VIa, aadA1, sul1 tet(A)
ST38 [2] – aac(3)-VIa*, aadA1*, aph(3′)-Ic*, strA, strB, tet(B), sul1*, sul2
ST1163 [1] – aac(3)-VIa, aadA1, sul1
ST373 [1] – –
ST9340 [1] – blaTEM-1b, aac(3)-VIa, aadA1, tet(A), sul1, dfrA1
IncA/C2 [3] pST3 ST355 [2] – aac(3)-VIa, aadA1, strA, strB, floR, tet(A), sul1, sul2
ST88 [1] – blaTEM-1b, aac(3)-VIa, aadA1, aadA2, strA, strB, cmlA1, floR, tet(A), sul1, sul2, sul3
blaCTX-M-55 IncFIB/IncFII [25] F18:A-:B1 ST457 [25] blaTEM-1b*, aph(3′)-Ia*, tet(A)*, sul2*, dfrA14* aac(3)-IIa*, aadA1*, strA*, strB*, floR*, sul3*
blaCTX-M-1 IncI1 [13] pST3b ST115 [3] aadA5*, tet(A)*, sul2*, dfrA17* –
ST117 [3] tet(A), sul2 –
ST155 [2] tet(A), sul2 blaTEM-1b, aadA5, aph(3′)-Ia, strA, strB, catA1, tet(B), , dfrA17
ST453 [2] tet(A), sul2 blaTEM-1b, strA, strB, dfrA14
ST23 [1] tet(A), sul2 blaTEM-1b, aadA1, sul3
ST2485 [1] tet(A), sul2 blaTEM-1b
ST753 [1] tet(A), sul2 blaTEM-1b, qnrS1
IncI2 [2] – ST38 [2] – aadA1, strA, strB, tet(A), mph(B), sul1, sul2, dfrA1
IncFIB/IncFII [1] Unknown ST4937 [1] – aadA1, strA, strB, catA1, tet(A), mph(A), sul1, dfrA1
IncHI2 [1] Unknown ST3107 [1] – aac(3)-IId, tet(A), sul2, dfrA14, dfrA17
blaSHV-12 IncX3 [12] - ST744 [8] qnrS1
blaTEM-1b, aadA5, aph(3′)-Ia*, strA, strB, catA1, tet(B), 
mph(A), sul1, sul2, dfrA17
ST1629 [3] qnrS1 tet(A), sul1
ST746 [1] qnrS1 cml, qnrA1, sul1, dfrA5
IncI1 [6] pST26 ST155 [3] – aadA1, aadA2, cmlA1, tet(A), sul3
pST26 ST4512 [1] – aadA1, aadA2, cmlA1, tet(A), sul3
pST95 ST117 [1] – aadA1, aadA2, cmlA1, tet(A), sul3
pST3 ST1303 [1] – blaTEM-1b, tet(A), qnrB19
blaCTX-M-65 Chromosome [4] – ST2179 [4] –
blaOXA-1, blaTEM-1a*, blaTEM-1b*, aadA1, aadA2, 
aadA5*, strA*, strB*, catB3, cmlA1, tet(A)*, qnrS2, 
mph(A)*, sul1*, sul2*, sul3, dfrA17*, arr-3*, aac(6′)
Ib-c
blaTEM-52b IncX1 [2] – ST388 [1] – qnrB19
ST695 [1] – –
blaCTX-M-2 IncQ1 [2] – ST4980 [2] – blaTEM-1b, aadA1, strA, strB, tet(A), sul1, sul2, dfrA1
blaCTX-M-15 IncY [1] – ST69 [1] – blaTEM-1b, strA, strB, tet(A), qnrS1, sul2
blaSHV-2 Untypable [1] – ST69 [1] – aadA1, aadA2, cmlA1, tet(A), sul3
Table 1.  Characteristics of 100 ESBL/pAmpC-EC isolates subjected to whole genome sequencing. a The 
IncB/O and IncK replicons were identified by PBRT. Further analysis indicated that these plasmids belong 
to the novel incompatibility group  IncK242. b Four isolates had truncated ardA genes in their assemblies but 
the other four alleles (pilL2, repI12, sogS1 and trbA4) were those of pST3. One isolate had also a truncated 
ardA gene and a novel sogS allele, differing from sogS1 by the mutation C24T. One isolate represented a novel 
IncI1 pST, closely related to pST3 ( ardA1→ ardA7). c Resistance genes in this column were found on the 
ESBL/pAmpC gene-carrying plasmids after analysis with ABACAS. The following plasmid types, found on 
76% of isolates, were studied: blaCMY-2-IncB/O/K/Z, blaCTX-M-55-IncFIB/IncFII, blaCTX-M-1- IncI1, blaSHV-12-
IncX3. Resistance genes marked with an asterisk indicate that they were not present in all the corresponding 
plasmids. d Resistance genes marked with an asterisk indicate that they were not present in all the isolates of the 
corresponding ST.
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IncFIB/FII plasmids carrying blaCTX‑M‑55. Interestingly, blaCTX-M-55 was found only on IncFIB/FII plasmids of 
replicon sequence type F18:A-:B1 (n = 25/25). This variant of the CTX-M enzyme has been mainly reported in 
Asian countries, where it represents the second most common variant in E. coli isolated from companion and 
livestock  animals55,56 and was only recently described in E. coli isolates of animal origin in  France18.
BLASTn analysis of the region including blaCTX-M-55 yielded homologous (99–100% nucleotide sequence iden-
tity) blaCTX-M-55-carrying F18:A-:B1 plasmids isolated from clinical E. coli isolates of human origin in the United 
States (GenBank accession nos. CP041997.1, KX276657.1, CP029748.1) and wastewater in Canada (GenBank 
accession no. MK878525.1). The human related plasmids additionally carried mcr colistin resistance genes. Here 
we used the mcr-1-carrying plasmid pMR0516mcr isolated from a clinical ST457 isolate (GenBank accession no. 
KX276657.1)17 as a reference sequence (Fig. 3d). In all of our ST457 isolates, the blaCTX-M-55 gene is associated with 
ISEcp1, within one of the most common genetic modules, ISEcp1-blaCTX-M-55-orf47757, and is located between 
the finO gene, which is involved in the regulation of plasmid conjugation, and the arsenic resistance operon ars 
(Fig. 3d). Other co-located resistance genes (e.g. blaTEM-1b, dfrA14, sul2) were found in varying combinations in 
the majority of our IncFIB/FII plasmids (Table 1).
conclusions and outlook
Our WGS approach revealed a complex landscape of E. coli genotypes present in the broiler production. We 
demonstrated that 76% of the sequenced isolates shared four dominant plasmid types that harboured ESBL/
pAmpC genes. The finding of diverse STs from various production stages, which share closely related plasmid 
backbones with identical ESBL/pAmpC gene insertions, is a strong indication that horizontal gene transfer via 
the exchange of plasmids that have been previously reported to be  transmissible42,46,52, plays a fundamental role 
in the dissemination of ESBL/pAmpC genes across the broiler production  pyramid5. In addition to β-lactamase 
genes, the sequenced isolates carried genes which conferred resistance to four other antimicrobial classes, on 
average, a fact that is relevant for public health and definitely needs to be considered in the hazard identifica-
tion step of a QMRA. The co-localisation of several other resistance genes on ESBL/pAmpC-carrying plasmids 
might explain their persistence and propagation through selection pressure by non-3GC antimicrobial  agents49. 
In addition to horizontal gene transfer, clonal expansion of several closely related ESBL/pAmpC-EC along the 
production pyramid was also observed and has been previously  reported58. The identification of phylogenetically 
related isolates in distantly located farms, but also in subsequent production levels of the same production chain, 
further supports the argument of clonal transmission from the top of the pyramid to the lower levels of produc-
tion. However, at least part of the ESBL/pAmpC-EC dissemination may be explained by indirect transmission 
events within the studied integrated production system (e.g. hatchery-to-farm or farm-to-farm transmission), 
which underlines the need to maintain and continuously monitor biosecurity protocols and thus prevent trans-
mission of ESBL/pAmpC-EC by e.g. the movement of vehicles, equipment and  personnel5. The importance of 
such measures is reflected by the fact that in accordance with other  studies22,59, in our recent prevalence  study13 
we encountered the lowest occurrence of ESBL/pAmpC-EC in PS breeders, a production stage where increased 
biosecurity standards are implemented due to the higher value of these flocks compared to fattening broilers. 
Also, as Hiroi et al.60 showed, contamination of the environment of broilers with ESBL/pAmpC-EC may be a 
more important factor for their colonisation than the use of antimicrobial agents.
We previously discussed a potential introduction of blaCMY-2 isolates through the import of day-old PS chicks, 
based on the finding that all isolates from this production stage had the phylogroup B2-blaCMY-2  genotype13. Here, 
we show that at least a part of these isolates belong to ST429/ST9298, a highly conserved blaCMY-2-positive lineage, 
which seems to be prevalent in the European poultry  production14. Results from the comparative analysis with 
ST429 genomes at Enterobase suggest the circulation of a conserved ST429/ST9298 lineage carrying blaCMY-2 
on IncK2 plasmids in the poultry production of at least five European countries, which needs to be studied 
further in future investigations, considering also the pathogenic potential of this ST for poultry and its role in 
colibacillosis (n = 7/8 isolates were APEC). Additionally, these findings further support the notion that ESBL/
pAmpC-EC may spread through the interconnected breeder stock supply  chains5,14,58, which warrants their 
eradication in pedigree flocks and in hatcheries. This can be achieved by e.g. the complete cessation of ceftiofur 
administration in these flocks for  prophylaxis61. Further, comparison with publicly available data proved that 
the occurrence of ESBL/pAmpC-EC in poultry is a dynamic phenomenon, since STs and ESBL/pAmpC genes 
not common in the European context, such as ST457 and blaCTX-M-55, can emerge and dominate in poultry. The 
fact that our E. coli isolates of ST457 and ST744 were closer related to human ones than to those originating 
from livestock (Fig. S2), raises questions about their ability to colonise the human gut upon exposure, transmit 
their resistance determinants, and/or exert their virulence potential. The latter aspect is especially relevant for 
ST457, which has a documented record of association with human disease and its isolates were assigned to 
defined pathotypes (ExPEC and/or EAEC) in our virulence analysis. Using an in vitro colon simulation system, 
Anjum et al.62 showed that E. coli isolated from human faeces and poultry meat were able to adapt and transmit 
their AMR plasmids to other Enterobacteriaceae in the human gut. Nevertheless, a recent study demonstrated 
that the dissemination of ESBL/pAmpC genes between animals and humans seems to be mediated by specific 
plasmid types rather than by expansion of successful E. coli  clones9. This hypothesis is further supported by the 
detection of closely related plasmid backbones with identical ESBL/pAmpC gene insertion sites between the 
isolates of this study and those of human  origin17,21,42,52.
Our isolate selection procedure was suitable for describing the diversity of ESBL/pAmpC-EC genotypes that 
may be encountered in the broiler production, studying the underlying transmission mechanisms and providing 
solid evidence of transmission events along the broiler production pyramid. However, our study has limita-
tions. Quantitative estimates on transmission pathways as well as statistical associations between the identified 
genotypes, which are essential for QMRAs, cannot be inferred with our analysis since this would require the 
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sequencing of a larger and more representative part of our initial collection of  isolates11. Such approaches are 
hampered by the decreasing but still significant cost of WGS. The second limitation concerns the findings of our 
comparative genomic analysis, which should be interpreted with caution since potential bias in Enterobase data 
may exist. Our objective was not to make deductions on potential transmission events between the analysed 
hosts, which would also require thorough epidemiological data, but to gain insights from the host distribution 
and phylogenetic relatedness of dominant ESBL/pAmpC-EC lineages in the context of an extensive collection 
of publicly available genomes supported by basic metadata. The two major conclusions on the highly conserved, 
poultry-related ST429-IncK2-blaCMY-2 and the emerging ST457-blaCTX-M-55 were noteworthy outcomes of this 
analysis that ought to be investigated further.
Our results provide valuable insights into the characteristics of ESBL/pAmpC-producing E. coli, their plasmid 
contents and distribution in the broiler production chain. These results contribute to the growing amount of 
available high throughput data that will serve as the baseline for future food chain QMRA models. For example, 
the AMR profile, the genetic context of resistance genes and the virulence potential of isolates described in this 
study are relevant for guiding the risk identification and characterisation  steps11. Given the key role of plasmids 
in the dissemination of ESBL/pAmpC genes elucidated here and in other  studies9, exposure assessment model-
ling should definitely include, if not prioritise on, the transfer probability of ESBL/pAmpC plasmids, especially 
of those with a wide host-spectrum. The output of such thorough QMRAs will be the risk estimate of human 
exposure to resistance determinants via the (broiler) food chain and the identification of intervention measures 
with the maximum mitigation  effect11.
Methods
Bacterial isolates. One-hundred isolates from a collection of ESBL/pAmpC-EC isolated from three pro-
duction chains, namely A (n = 37), B (n = 32), and C (n = 31), of an integrated broiler company in Italy were 
included in this  study13. Briefly, we sampled with cloacal swabs one PS flock per production chain at two time 
points; (i) one-day-old PS chicks upon arrival at the rearing farms and (ii) PS breeders at ~ 21 weeks of age dur-
ing the laying period at the production farms. Afterwards, the offspring of the PS flock were sampled in four 
fattening farms per production chain at the start (one-day-old) and the end (~ 30-days-old) of the production 
cycle (broiler chicks and broilers, respectively). Carcasses from the sampled broilers were collected at the slaugh-
terhouse after chilling and isolation of ESBL/pAmpC-EC was performed after rinsing the whole carcass with 
buffer peptone  water13. E. coli phylogenetic groups and ESBL/pAmpC genes have been previously determined 
for these isolates by PCR and  sequencing13. At least one isolate per production chain, production stage, ESBL/
pAmpC gene, and phylogroup combination (e.g. isolate EC-1 in File S1, chain A/PS chicks/blaCMY-2/phylogroup 
B2) was randomly selected for sequencing to fully explore the diversity of ESBL/pAmpC-EC genotypes across 
the production pyramid and identify potential transmission events. The 100 selected isolates originated from the 
following production stages: PS chicks (n = 5), PS breeders (n = 8), broiler chicks (n = 26), broilers (n = 28) and 
slaughterhouse/carcass (n = 33) (File S1).
Whole genome sequencing and in silico typing. DNA extraction and sequencing were carried out 
at two different sites. At the first site, DNA was isolated from 32 isolates with the Master Pure Genomic DNA-
Purification Kit (Epicenter, USA), libraries were prepared with the Nextera XT library preparation kit (Illumina, 
USA) and sequencing on an Illumina MiSeq platform using the MiSeq v3 reagent kit (Illumina) with 2 × 300 bp 
paired-end reads. At the second site, DNA was isolated from 68 isolates with the Invisorb Spin Tissue Mini Kit 
(Invitek, Germany), library preparation was done with the Nextera XT library preparation kit and sequencing on 
an Illumina HiSeqX platform with 2 × 150 bp paired-end reads at a private company (Macrogen, Korea).
Raw reads were directly submitted for processing at the Enterobase  database63. The Enterobase backend 
pipeline assures high quality assemblies by including reads pre-processing and post-correction of  SPAdes64 
assemblies (https ://enter obase .readt hedoc s.io/). Assemblies that did not meet the quality control criteria were 
not used for downstream analysis. Assembly statistics (coverage, N50, genome size and contig number) and 
accession numbers (Enterobase barcodes) for each strain can be found in File S1. Further, sequenced isolates 
were genotyped in silico with regard to acquired resistance genes and chromosomal mutations (ResFinder 3.2 
and PointFinder 3.1, respectively)20, as well as plasmid replicon types (PlasmidFinder 2.0)65 and pSTs when avail-
able (pMLST 2.0)65, using the tools at default settings, whereas E. coli STs were extracted from the Enterobase 
automated pipeline, which follows the Achtman MLST scheme.66 Presence of VGs was assessed with  BLAST67 
alignments (E < 10–5) to the Virulence Factors Database (VFDB)68 extended with VGs from literature (hlyF, iss, 
ompT)31,34. Based on their virulence gene content, isolates were assigned to known  pathotypes33–36. A VG was 
considered to be associated to a given ST if at least 80% of the isolates included in that ST carried the specific VG.
Plasmid characterisation. In several isolates, the ESBL/pAmpC gene-carrying plasmid was identified by 
the presence of the resistance gene and the plasmid replicon on the same contig. Otherwise, the contigs con-
taining ESBL/pAmpC genes but missing the plasmid replicon were compared by  BLASTn67 (default settings) 
to the most similar, complete reference plasmids available in GenBank database. To identify all the contigs cor-
responding to particular plasmids, the draft genome of each isolate and the reference plasmid were aligned with 
 ABACAS69 as previously  described70. Identification of the genetic context of ESBL/pAmpC genes was done by 
aligning the identified plasmid contigs against the reference plasmid in Geneious 10.1.3, using the multiple 
alignment tool and default settings.  EasyFig71 was used to visualise aligned plasmid regions of interest.
To confirm results obtained in silico, plasmid transformation experiments were performed for at least one 
isolate with a specific ST/ESBL/pAmpC gene combination, resulting in a total of 32 plasmid transformations. 
Briefly, plasmid DNA was extracted with the alkaline lysis  method72, electro-competent DH5α E. coli cells 
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(Invitrogen, Denmark) were prepared according to Smith et al.73 and transformed by electroporation utilizing 
an Eppendorf Eporator (Eppendorf, Germany). Potential transformants harbouring an ESBL/pAmpC-carrying 
plasmid were isolated on LB agar (Microbiol, Italy) containing 1 mg/L cefotaxime. The incompatibility group 
of plasmids transferred from the wild type isolates was determined by PCR-based replicon typing (PBRT)74,75.
Phylogenetic analysis. The phylogeny of the sequenced isolates was deduced by a SNP-based mapping 
analysis. A suitable reference was selected among all complete E. coli genomes (n = 983) (https ://www.ncbi.
nlm.nih.gov/genom e/167) using  Mash76 to find the reference genome with the least Mash distance from (i) all 
sequenced isolates and (ii) all isolates of each dominant ST group. The phylogenetic analysis was extended with 
all publicly available genomes at Enterobase, belonging to the most dominant STs of our collection and with a 
confirmed presence of ESBL/pAmpC genes by local ResFinder analysis. E. coli genomes were mapped to the 
selected reference (File S2) and a maximum likelihood SNP tree was created with CSI  phylogeny77 using default 
settings. Cluster calculation was performed with the hierBAPS module of the Bayesian Analysis of Popula-
tion Structure (BAPS) software v6.078. BAPS clusters were assigned based on the output SNP alignment of CSI 
phylogeny with 2 levels of hierarchy and a maximum number of cluster (K) equal to the number of ST groups 
(n = 31) in the phylogenetic analysis of sequenced isolates, and equal to the number of isolates in the phyloge-
netic analysis of each ST group. All phylogenetic trees (Figs. 1, S1 and S2) generated with CSI phylogeny were 
visualised as phylograms and annotated with metadata in CLC Genomics Workbench version 12.0 (Qiagen, 
Denmark). The Mash-based ranking of complete reference genomes and their NCBI accession numbers, the 
barcodes of Enterobase genomes used for the comparative genomic analysis and the statistics of the SNP analysis 
(e.g. % reference coverage, number of SNPs) can be found in File S2.
Ethics statement. Collection of cloacal swabs from live birds in the study of Apostolakos et al.13, was done 
by veterinarians of the private poultry company as part of the routine monitoring of the flock health status and 
conducted in compliance with good veterinary practices. This routine monitoring does not require approval by 
an institutional and/or licensing committee.
Data availability
All data generated or analysed during this study are included in this published article and its Supplementary 
Information files.
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